1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for OSTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2025. Start Trial.
Date Value
September 22, 2026 -19.91%
September 21, 2026 -17.92%
September 18, 2026 -19.91%
September 17, 2026 -16.82%
September 16, 2026 -21.17%
September 15, 2026 -19.09%
September 14, 2026 -24.44%
September 11, 2026 -27.27%
September 10, 2026 -17.27%
September 09, 2026 -15.07%
September 08, 2026 -18.30%
September 04, 2026 -10.05%
September 03, 2026 -13.33%
September 02, 2026 -22.97%
September 01, 2026 -30.54%
August 31, 2026 -29.29%
August 28, 2026 -27.43%
August 27, 2026 -32.80%
August 26, 2026 -29.18%
August 25, 2026 -24.66%
August 24, 2026 -37.50%
August 21, 2026 -33.75%
August 20, 2026 -27.85%
August 19, 2026 -32.09%
August 18, 2026 -33.94%
Date Value
August 17, 2026 -28.64%
August 14, 2026 -24.65%
August 13, 2026 -14.89%
August 12, 2026 -9.55%
August 11, 2026 -4.19%
August 10, 2026 -5.78%
August 07, 2026 -8.57%
August 06, 2026 -6.86%
August 05, 2026 -6.98%
August 04, 2026 -5.78%
August 03, 2026 -11.43%
July 31, 2026 -14.61%
July 30, 2026 -10.86%
July 29, 2026 -19.13%
July 28, 2026 -16.67%
July 27, 2026 -15.00%
July 24, 2026 -12.14%
July 23, 2026 -14.75%
July 22, 2026 -14.84%
July 21, 2026 -7.69%
July 20, 2026 -7.93%
July 17, 2026 -8.93%
July 16, 2026 -10.71%
July 15, 2026 -1.90%
July 14, 2026 6.41%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 7.66%
Alnylam Pharmaceuticals, Inc. -45.16%
Anika Therapeutics, Inc. 123.7%
Savara, Inc. 51.86%
Vericel Corp. 26.44%